These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 33128247)
1. Micro- and macrovascular cardiac allograft vasculopathy in relation to 91 cardiovascular biomarkers in heart transplant recipients-An exploratory study. Bjerre KP; Clemmensen TS; Poulsen SH; Hvas AM; Holm NR; Grove EL; Bouchelouche K; Kristensen SD; Eiskjaer H Clin Transplant; 2021 Jan; 35(1):e14133. PubMed ID: 33128247 [TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation. Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998 [TBL] [Abstract][Full Text] [Related]
3. Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial. Broch K; Gude E; Karason K; Dellgren G; Rådegran G; Gjesdal G; Gustafsson F; Eiskjaer H; Lommi J; Pentikäinen M; Lemström KB; Andreassen AK; Gullestad L Clin Transplant; 2020 Sep; 34(9):e13984. PubMed ID: 32445429 [TBL] [Abstract][Full Text] [Related]
4. Abnormal mitochondrial function and morphology in heart transplanted patients with cardiac allograft vasculopathy. Lichscheidt ED; Jespersen NR; Nielsen BRR; Berg K; Seefeldt J; Nyengaard JR; Bøtker HE; Eiskjær H J Heart Lung Transplant; 2022 Jun; 41(6):732-741. PubMed ID: 35249802 [TBL] [Abstract][Full Text] [Related]
5. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT. Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670 [TBL] [Abstract][Full Text] [Related]
6. Platelet aggregation and response to aspirin therapy in cardiac allograft vasculopathy. Bjerre KP; Clemmensen TS; Berg K; Poulsen SH; Hvas AM; Grove EL; Løgstrup BB; Jakobsen L; Thim T; Kristensen SD; Eiskjær H J Heart Lung Transplant; 2020 Apr; 39(4):371-378. PubMed ID: 32067865 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale. Van Keer JM; Van Aelst LNL; Rega F; Droogne W; Voros G; Meyns B; Vanhaecke J; Emonds MP; Janssens S; Naesens M; Van Cleemput J J Heart Lung Transplant; 2019 Nov; 38(11):1189-1196. PubMed ID: 31543298 [TBL] [Abstract][Full Text] [Related]
8. Biomarker discovery in cardiac allograft vasculopathy using targeted aptamer proteomics. Almufleh A; Zhang L; Mielniczuk LM; Stadnick E; Davies RA; Du Q; Rayner K; Liu PP; Chih S Clin Transplant; 2020 Jan; 34(1):e13765. PubMed ID: 31815308 [TBL] [Abstract][Full Text] [Related]
9. Noninvasive Physiologic Assessment of Cardiac Allograft Vasculopathy Is Prognostic for Post-Transplant Events. Clerkin KJ; Topkara VK; Farr MA; Jain R; Colombo PC; Restaino S; Sayer G; Castillo M; Lam EY; Chernovolenko M; Yuzefpolskaya M; DeFilippis E; Latif F; Zorn E; Takeda K; Johnson LL; Uriel N; Einstein AJ J Am Coll Cardiol; 2022 Oct; 80(17):1617-1628. PubMed ID: 36265957 [TBL] [Abstract][Full Text] [Related]
11. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation. Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779 [TBL] [Abstract][Full Text] [Related]
12. Detection of cardiac allograft vasculopathy on dual source computed tomography in heart transplant recipients: comparison with invasive coronary angiography. Ojha V; Ganga KP; Mani A; Jagia P; Gulati G; Seth S; Nakra T; Arava S; Kumar S; Ray R; Sharma S Br J Radiol; 2022 Jun; 95(1134):20211237. PubMed ID: 35230144 [TBL] [Abstract][Full Text] [Related]
13. Intravascular ultrasound-guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients. Nelson LM; Rossing K; Ihlemann N; Boesgaard S; Engstrøm T; Gustafsson F Clin Transplant; 2020 Dec; 34(12):e14124. PubMed ID: 33068292 [TBL] [Abstract][Full Text] [Related]
14. Epicardial fat volume is related to the degree of cardiac allograft vasculopathy. Roest S; Budde RPJ; Brugts JJ; von der Thüsen J; van Walsum T; Taverne YJHJ; Zijlstra F; Bos D; Manintveld OC Eur Radiol; 2023 Jan; 33(1):330-338. PubMed ID: 35986769 [TBL] [Abstract][Full Text] [Related]
15. The novel proteomic signature for cardiac allograft vasculopathy. Wei D; Trenson S; Van Keer JM; Melgarejo J; Cutsforth E; Thijs L; He T; Latosinska A; Ciarka A; Vanassche T; Van Aelst L; Janssens S; Van Cleemput J; Mischak H; Staessen JA; Verhamme P; Zhang ZY ESC Heart Fail; 2022 Apr; 9(2):1216-1227. PubMed ID: 35005846 [TBL] [Abstract][Full Text] [Related]
16. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation. Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P; Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361 [TBL] [Abstract][Full Text] [Related]
17. Burden of arrhythmia and silent ischemia in heart transplant patients with cardiac allograft vasculopathy. Berg K; Bjerre KP; Clemmensen TS; Løgstrup BB; Mølgaard H; Poulsen SH; Eiskjær H Scand Cardiovasc J; 2021 Oct; 55(5):300-307. PubMed ID: 34313167 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of longitudinal myocardial deformation by 2-dimensional speckle-tracking echocardiography in heart transplant recipients: relation to coronary allograft vasculopathy. Clemmensen TS; Løgstrup BB; Eiskjær H; Poulsen SH J Heart Lung Transplant; 2015 Feb; 34(2):195-203. PubMed ID: 25108908 [TBL] [Abstract][Full Text] [Related]
19. Heart rate and early progression of cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis. Pazdernik M; Wichterle D; Chen Z; Bedanova H; Kautzner J; Melenovsky V; Karmazin V; Malek I; Stiavnicky P; Tomasek A; Ozabalova E; Krejci J; Wahle A; Zhang H; Kovarnik T; Sonka M Clin Transplant; 2020 Feb; 34(2):e13773. PubMed ID: 31859379 [TBL] [Abstract][Full Text] [Related]
20. Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients. Javaheri A; Molina M; Zamani P; Rodrigues A; Novak E; Chambers S; Stutman P; Maslanek W; Williams M; Lilly SM; Heeger P; Sayegh MH; Chandraker A; Briscoe DM; Daly KP; Starling R; Ikle D; Christie J; Rame JE; Goldberg LR; Billheimer J; Rader DJ J Heart Lung Transplant; 2016 Nov; 35(11):1295-1302. PubMed ID: 27498384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]